Effect of Vitamin C Supplementation on HbA1c in Type 2 Diabetic Patients
Not Applicable
- Conditions
- Nutritional, Metabolic, Endocrine
- Registration Number
- PACTR202006610508575
- Lead Sponsor
- Dina hosny Elsaka
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
1-Adults with type 2 diabetes (30-60)
2-Diabetics on non-insulin pharmacologic agents.
3-With HbAlc concentrations of >7 % according to glycemic targets in ADA 2020
Exclusion Criteria
1-Patients Enrolled in another research study and receiving another modality.
2-Type 1 diabetics and type 2 on insulin.
3-Pregnant or lactating women.
4-Postmenauposal women.
5-Known Severe or uncontrolled cardiovascular disease.
6-Patients with a known history of cognitive impairment interfering with treatment compliance.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method - HbA1c was measured on 12th weeks of the therapy and compared to the pre-intervention level.
- Secondary Outcome Measures
Name Time Method body mass index